Keywords: Hyperpolarized MR (Non-Gas), Hyperpolarized MR (Non-Gas), Small animals, MRI, imaging, 13C Spectroscopy, probes, Hepatocellular Carcinoma, HCC, Liver, cancer, amino acids
Motivation: Aberrant activation of the CTNNB1/Wnt pathway is a common molecular alteration in Hepatocellular Carcinoma (HCC) that has been found to impact patients’ response to therapy; however, there is a deficiency of non-invasive biomarkers for stratifying HCC patients based on CTNNB1 mutational status.
Goal(s): We sought to identify a novel non-invasive molecular imaging biomarker of CTNNB1/Wnt pathway mutation in HCCs.
Approach: We assessed metabolic flux in clinically relevant HCC patient-derived xenografts in vivo using Hyperpolarized 1-13C Pyruvate Magnetic Resonance Spectroscopy.
Results: We observed an 86% higher and 14% lower Hyperpolarized 1-13C Pyruvate conversion to Alanine and Lactate respectively in CTNNB1mutant HCCs compared to non-mutants.
Impact: CTNNB1 mutant and non-mutant HCCs can be distinguished non-invasively by assessing Hyperpolarized-1-13C-Pyruvate flux to Alanine and Lactate. Our findings present a promising precision imaging strategy for patient stratification, with the potential to enhance treatment outcomes in HCC and other cancers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords